Clinical Management Guidelines for STK11 Variants

This guide outlines clinical management guidelines for patients with a pathogenic or likely pathogenic variant in the STK11 gene, specifically related to Peutz-Jeghers syndrome. It references the medical management guidelines issued by the National Comprehensive Cancer Network (NCCN) and emphasizes the importance of individualized treatment plans based on the patient's medical history and genetic testing results. The document details various cancer screening recommendations, including the age to start screenings and their frequency for different types of cancer such as breast, colorectal, gastric, small intestine, pancreatic, ovarian, cervical, and uterine cancers. It also discusses the implications of genetic testing for family members and the potential risks associated with the STK11 variant. The guide stresses the need for discussions between patients and healthcare providers to tailor management decisions and emphasizes that the information provided is not a substitute for professional medical advice.